Stay updated on CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial

Sign up to get notified when there's something new on the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2, and the previous Notice about lapse in government funding and Revision: v3.4.1 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T04:57:10.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A system notice about potential processing delays due to a lapse in government funding was added, the NIH Clinical Center is open, and the page revision was updated to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T03:41:20.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Show glossary feature added; new labels include 'Last Update Submitted that Met QC Criteria' and the footer 'Revision: v3.4.0'. The previous QC label 'Last Update Submitted that met QC Criteria', 'No FEAR Act data' and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-28T00:27:56.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed as a minor site revision update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-13T19:12:21.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Introduced a Locations section listing study sites in California, Connecticut, Florida, New York, Texas, Utah, New South Wales, and Ontario, reorganizing location details under a single header. The page revision is updated to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T08:28:40.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page now shows a new revision label 'Revision: v3.3.2', replacing the previous 'v3.3.1'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:49:35.000Z thumbnail image

Stay in the know with updates to CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page.